-
The State Food and Drug Administration regulates the filing and reporting of online drug sales
Time of Update: 2023-01-01
js?cdnversion='+~(-new Date()/36e5)];In accordance with the requirements of the Measures for the Supervision and Administration of Online Sales of Drugs, in order to guide drug regulatory departments at all levels to orderly carry out the filing of third-party platforms for drug online transactions and the reporting of pharmaceutical online sales enterprises, the relevant matters are hereby announced as follows: 1.
-
The team of Xu Yikai of Nanfang Hospital has published a series of new results in internationally renowned academic journals
Time of Update: 2022-11-04
Recently, the research results of Professor Xu Yikai's team in the field of tumor molecular imaging and functional imaging of Nanfang Hospital have been published online in internationally renowned j
-
Biliflow tablets were successfully exported to Canada and Hutchison Pharmaceutical realized the dream of Chinese medicine internationalization
Time of Update: 2022-10-25
On October 14, Biliflow (Canadian trade name: Biliflow) held a loading and delivery ceremony at the Fengpu R&D and production base of Shanghai Hehuang Pharmaceutical. The batch of drugs will be sent t
-
【Cell】 Shi Hubing/Jingjing team of West China Hospital revealed the drug resistance mechanism of triple-negative breast cancer to MEK inhibitors
Time of Update: 2022-10-02
On September 12, a team led by Professor Shi Hubing of the State Key Laboratory of Biotherapy at West China Hospital of Sichuan University and Professor Jing Jing of West China Hospital of Sichuan University published an article entitled "PSMG2-controlled proteasome-autophagy balance mediates the tolerance for MEK-targeted therapy in" in Cell Reports Medicine triple-negative breast cancer" research paper.
-
The researchers tested a new hypothesis that explains the autoimmunity of people with type 1 diabetes
Time of Update: 2022-10-01
essayHypothesis: Induction of Autoimmunity in Type 1 Diabetes—A Lipid Focus Type 1 diabetes mellitus (T1D) is an autoimmune disease in which the pancreas secretes little or no insulin.
-
A collection of research progress at the 2022 EBMT Annual Meeting
Time of Update: 2022-04-27
For details, please see: 2022 EBMT | ASCT still plays an important role in multiple myeloma patients in the era of new drugs Italian and Turkish researchers conducted studies to explore the use of allogeneic hematopoietic stem cell transplantation in elderly patients with acute myeloid leukemia (AML) ( allo-HSCT) .
-
The achievements of Liu Tao's team were selected as the top ten domestic medical science and technology news in 2021
Time of Update: 2022-02-20
Liu Tao's team from Peking University School of Pharmacy and Ye Haifeng's team from East China Normal University School of Life Sciences jointly developed a gene "switch" that rapidly regulates insulin expression, providing a new tool for synthetic biology and cell therapy research .
-
Is it more and more difficult for Chinese patent medicine companies to increase the price of a large number of Chinese herbal medicines
Time of Update: 2022-01-22
For the price increase of Chinese patent medicine, many pharmaceutical companies attribute the reason to the general price increase of traditional Chinese medicine raw materials due to factors such as climate and planting area, especially the scarcity of superimposed resources of precious and fine raw materials and the impact of contradiction between supply and demand .
-
The results of medical insurance negotiations may be announced at the end of November
Time of Update: 2021-12-07
In this year's medical insurance negotiations, Bojian's three rare disease drugs, including noxinagen sodium, dimethyl fumarate, and fampridine, passed the initial formal review of the national medical insurance drug catalog adjustment and appeared at the negotiation site .
-
A pharmacy chain giant has spent huge sums of money to acquire 198 stores
Time of Update: 2021-09-29
A few days ago, Shuyu civilians announced that the company intends to acquire 100% of Qihe Taiyao held by Jilin Jingyao and Zhushan Leichi for no more than 288 million yuan, thereby indirectly holding 80% of the equity of Spring Pharmaceutical.
-
2021 West Lake Forum | Guangshengyuan He Lei: Breaking "silly, big, black, and rough
Time of Update: 2021-05-02
During the meeting, He Lei, general manager of the business center of Guangshengyuan Traditional Chinese Medicine Co.
He Lei, general manager of the business center of Guangshengyuan Traditional Chinese Medicine Co.
He Lei, general manager of the business center of Guangshengyuan Traditional Chinese Medicine Co.
-
Industry | The Forbes Billionaires List is released, and the chairman of Three Trees is on the list for the first time
Time of Update: 2021-03-28
75em; text-indent: 2em; text-align: center;">Hong Jie, the chairman of Three Trees, from the mainland of China, entered the global rich list for the first time this year, and ranked 1613 with a net worth of US$1.
-
List of experts for the first round of evaluation of key special declaration projects in synthetic biology
Time of Update: 2021-02-27
according to the key special evaluation work arrangement, the Biological Center organized the first round of the 2020 annual declaration project for synthetic biology from June 12 to June 18, 2020.
This review uses the network evaluation method, the evaluation experts unified from the national science and technology expert pool, a total of 15 people.
-
Buy 4 common medicines from pharmacies without a prescription
Time of Update: 2021-01-11
the common name of the drug: Chai Yin particles Chinese Pinyin: s/he used for upper respiratory tract infection external sense of wind fever evidence, the symptoms see: fever, headache, sore throat, sweating, nasal congestion runny nose, cough, tongue sharp red, moss yellow and other diseases.
-
Pharmaceutical companies continue to change capital, spin-off listing into a boom
Time of Update: 2020-11-11
, as on August 9th, Lizhu Group announced that it intended to spin off its controlling subsidiary Lizhu Reagent to list on the A-share market.
